BiotechTube

Imrecoxib

ApprovedUNKNOWN
1 views this week 0 watching💤 Quiet
Interest: 39/100
39
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Knee Osteoarthritis

Conditions

Knee Osteoarthritis

Trial Timeline

May 1, 2013 → —

NCT ID
NCT01985165

About Imrecoxib

Imrecoxib is a approved stage product being developed by Jiangsu Hengrui Medicine for Knee Osteoarthritis. The current trial status is unknown. This product is registered under clinical trial identifier NCT01985165. Target conditions include Knee Osteoarthritis.

What happened to similar drugs?

10 of 20 similar drugs in Knee Osteoarthritis were approved

Approved (10) Terminated (0) Active (10)
✅NISEDr. Reddy's LaboratoriesApproved
✅Capsaicin Topical SolutionAstellas PharmaApproved
✅celecoxibPfizerApproved
✅Ibuprofen + Placebo + CelecoxibPfizerApproved
✅Celecoxib + Naproxen + PlaceboPfizerApproved
✅Celecoxib + PlaceboPfizerApproved
✅Ibuprofen + celecoxibPfizerApproved

Hype Score Breakdown

Clinical
20
Activity
4
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT02456688Phase 1UNKNOWN
NCT01985165ApprovedUNKNOWN

Competing Products

20 competing products in Knee Osteoarthritis

See all competitors
ProductCompanyStageHype Score
NISEDr. Reddy's LaboratoriesApproved
40
NISELATDr. Reddy's LaboratoriesPre-clinical
23
LY2828360 + PlaceboEli LillyPhase 2
35
UBX0101 or placeboUnity BiotechnologyPre-clinical
8
UBX0101Unity BiotechnologyPhase 1
19
UBX0101Unity BiotechnologyPhase 2
25
UBX0101Unity BiotechnologyPhase 1
19
YH23537 + Celecoxib + YH23537 placeboYuhanPhase 2
35
YM150 + WarfarinAstellas PharmaPhase 2
35
ASP7962 + Naproxen + PlaceboAstellas PharmaPhase 2
35
Capsaicin Topical SolutionAstellas PharmaApproved
43
CGS-200-1 + CGS-200-5 + CGS-200 VehicleAstellas PharmaPhase 2
35
MM-II dose I + MM-II dose II + MM-II dose III + Placebo + Placebo + PlaceboSun PharmaceuticalPhase 2
35
Duloxetine + PlaceboShionogiPhase 3
40
DuloxetineShionogiPhase 3
40
V120083 + Naproxen + PlaceboShionogiPhase 2
35
ONO-4474 + Placebo matching ONO-4474Ono PharmaceuticalPhase 2
27
Duloxetine + PlaceboEli LillyPhase 3
40
Duloxetine (DLX) + Placebo (PLA)Eli LillyPhase 3
40
Duloxetine + placeboEli LillyPhase 3
40